Alexandria M. Lopez
About Alexandria M. Lopez
Alexandria M. Lopez is Chief Financial Officer and a Director of Maison Solutions Inc. (NASDAQ: MSS). She has served as CFO since 2019 and on the Board since 2019; age 40; B.A. in Accounting from the University of Phoenix . Company performance during her current tenure includes Q3 FY2025 net revenues of $34.1M (+151% YoY), EBITDA of $1.5M (vs. $(0.21)M prior-year), and nine-month FY2025 EBITDA of $4.0M with net income of $1.5M, reflecting contributions from the Lee Lee acquisition and operational improvements .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| J&C International Group LLC | Chief Financial Officer & Vice President | 2014–2023 | Financial leadership at cross-border investment firm; experience relevant to MSS growth and M&A |
| Maison Solutions Inc. | Chief Financial Officer | 2019–Present | Led finance through IPO (2023), integration of Lee Lee (2024), and scale-up to 7 stores |
External Roles
No other public-company directorships or external board roles disclosed for Ms. Lopez .
Fixed Compensation
| Metric | FY 2023 | FY 2024 |
|---|---|---|
| Base Salary ($) | 106,000 | 106,000 |
| Bonus ($) | 0 | 0 |
| Director Fees ($) | 0 (employee-directors receive no additional fees) | 0 (employee-directors receive no additional fees) |
Performance Compensation
| Incentive Type | Metric | Weighting | Target | Actual | Payout ($) | Vesting |
|---|---|---|---|---|---|---|
| Annual Cash Incentive | Not disclosed | N/A | N/A | N/A | 0 | N/A |
| Stock Awards (RSUs/PSUs) | Not granted | N/A | N/A | N/A | 0 | N/A |
| Stock Options | Not granted | N/A | N/A | N/A | 0 | N/A |
The proxy states: “None of our named executive officers have ever held options… or other awards with values based on the value of its interests.” As of April 30, 2024, no shares had been issued under the 2023 Stock Incentive Plan .
Equity Ownership & Alignment
| Metric | As of Mar 28, 2025 |
|---|---|
| Shares Beneficially Owned (Class A/B) | None reported for Ms. Lopez |
| Ownership % of Outstanding | <1% (not listed; table shows dashes) |
| Vested vs. Unvested Shares | Not applicable (no grants disclosed) |
| Options (Exercisable/Unexercisable) | None |
| Shares Pledged | Not disclosed |
| Ownership Guidelines | Not disclosed |
| Clawback Coverage | Company-wide clawback policy adopted; applies to incentive comp post-restatement |
Employment Terms
| Term | Detail |
|---|---|
| Agreement Effective | October 1, 2021 |
| Role | Chief Financial Officer |
| Base Salary | $106,000 per year |
| Term & Renewal | Initial 1-year term; auto-renews for successive 1-year periods; at-will employment |
| Non-Compete/Non-Solicit | Included in agreement |
| Termination/Remedy | If Ms. Lopez violates terms, company may terminate without notice; one-month salary as compensation and exclusive remedy |
| Severance (without cause) | Not disclosed beyond violation remedy; no severance multiple disclosed |
| Change-of-Control | Not disclosed |
| Deferred Compensation/Pension | Not disclosed |
| Perquisites | Not disclosed |
Board Governance (Director Service, Committees, Independence, Dual-Role Implications)
- Board Service: Director since 2019; attends at least 75% of meetings; Board held 3 meetings and 7 consent actions in FY ended Apr 30, 2024 .
- Committee Roles: Ms. Lopez is not listed on Audit, Compensation, or Nominating & Corporate Governance committees (all independent members: Willis, Wang, Zhang) .
- Independence: MSS is a controlled company; only Wang, Willis, Zhang are independent. Ms. Lopez (CFO) is not independent .
- Board Leadership: CEO serves as Chairman; Lead Independent Director is Mark Willis .
- Dual-role implications: Executive officer serving as director under controlled company framework; compensation and nominations may rely on controlled-company exemptions from Nasdaq independence rules .
Director Compensation (Context)
| Non-Employee Director | Fees Earned (FY 2024) |
|---|---|
| Mark Willis | 50,000 |
| Bin Wang | 50,000 |
| Dr. Xiaoxia Zhang | 50,000 |
- Employee-directors (e.g., Ms. Lopez) receive no additional director compensation; standard director service agreements include $50,000 retainer for non-employee directors and indemnification .
Performance & Track Record (Company Context During Her Tenure)
| Metric | Q3 FY2024 | Q3 FY2025 |
|---|---|---|
| Net Revenues ($M) | 13.6 | 34.1 |
| Gross Profit ($M) | 3.2 | 7.5 |
| Gross Margin (%) | 23.4% | 22.1% |
| EBITDA ($M) | (0.21) | 1.52 |
| Net Income ($M) | (0.55) | 1.00 |
| Metric | 9M FY2024 | 9M FY2025 |
|---|---|---|
| Net Revenues ($M) | 41.1 | 94.8 |
| Gross Profit ($M) | 9.4 | 24.0 |
| Gross Margin (%) | 22.9% | 25.3% |
| EBITDA ($M) | 0.32 | 3.97 |
| Net Income ($M) | (0.56) | 1.50 |
- FY2025 Guidance (reiterated Mar 17, 2025): Revenues $120–$125M; net income positive .
- Strategic initiatives cited by management: consultancy agreement generating $1.3M annually, Lee Lee integration, renovation program, COO appointment .
Compensation Committee Analysis
- Composition: Independent directors Mark Willis (Chair), Bin Wang, Dr. Xiaoxia Zhang .
- Charter: Oversees compensation practices/policies, equity plans, key employee compensation; prepares recommendations to Board .
- Activity: No meetings; one action by unanimous written consent in FY ended Apr 30, 2024 .
- Controlled company exemptions allow CEO compensation determination not solely by independents; MSS indicates reliance on Nasdaq exemptions .
Related Party Transactions (Governance Context)
- Multiple transactions with entities controlled by CEO John Xu and spouse; purchase and sales with affiliates; payables to related parties; acquisition of Maison Monterey Park from related parties (price amended to $2.5M) .
- Concentration of ownership and voting power: John Xu beneficially owns ~77.93% of Class A and 100% of Class B (90.34% voting power) .
Risk Indicators & Red Flags
- Controlled company with dual-class structure; CEO holds majority voting power; exemptions from some Nasdaq governance rules .
- Material weaknesses in internal control over financial reporting (insufficient accounting expertise; related party monitoring; inventory controls; IT general controls; segregation of duties) .
- Convertible financing entered March 2025 (Initial Note $3.0M, Incremental Warrant up to $6.5M); potential issuance up to 62.7M shares at Floor Price; Exchange Cap removal requires stockholder approval; significant dilution risk noted .
- Ongoing/possible litigation (securities class actions/derivative actions) disclosed; potential cost, management distraction, reputational impact .
- Extensive related party transactions create potential conflicts; recognized as a risk factor .
Investment Implications
- Pay-for-performance alignment is limited at the CFO level: fixed salary only, no bonus paid, no equity awards/options, and no disclosed performance metrics or vesting schedules—reducing near-term insider selling pressure but also limiting equity alignment; Ms. Lopez reported no beneficial ownership as of Mar 28, 2025 .
- Governance mitigants include independent committees and a clawback policy; however, controlled-company status (CEO as Chairman, lead independent director structure) concentrates control and permits reliance on Nasdaq exemptions, necessitating investor monitoring of compensation decisions and related party transactions .
- Company-level dilution and financing structure (convertible notes with variable pricing) are likely stronger drivers of trading signals than CFO-specific actions, with potential share overhang and price volatility if conversions accelerate; monitor shareholder approvals and conversion activity timelines .
- Execution risk remains in remediating material weaknesses and integrating operations (Lee Lee, center-satellite strategy), areas where CFO oversight is critical; sustained improvements in controls and disclosures would be positive signals .